1978
DOI: 10.1620/tjem.124.197
|View full text |Cite
|
Sign up to set email alerts
|

Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1979
1979
1992
1992

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(2 citation statements)
references
References 21 publications
0
2
0
Order By: Relevance
“…1 2 Moreover, patients with essential hypertension and low basal rates of kallikrein excretion have been reported to exhibit blunted increases in PRA associated with concomitantly reduced increments in urinary kallikrein excretion when compared to normal subjects in response to furosemide. 10 In addition, besides our demonstration of its suppressive effect on furosemide-stimulated renin release in the rabbit, 5 aprotinin was subsequently shown to inhibit both of these effects of furosemide simultaneously in the rat. 12 Although components of the kallikrein-kinen system were not measured in our studies, the fact that aprotinin 6 and amiloride 8 both inhibit glandular kallikrein activity strongly suggests that their strikingly similar ability to suppress the stimulated rise in PRA produced by furosemide might be mediated via an inhibition of this system.…”
mentioning
confidence: 76%
See 1 more Smart Citation
“…1 2 Moreover, patients with essential hypertension and low basal rates of kallikrein excretion have been reported to exhibit blunted increases in PRA associated with concomitantly reduced increments in urinary kallikrein excretion when compared to normal subjects in response to furosemide. 10 In addition, besides our demonstration of its suppressive effect on furosemide-stimulated renin release in the rabbit, 5 aprotinin was subsequently shown to inhibit both of these effects of furosemide simultaneously in the rat. 12 Although components of the kallikrein-kinen system were not measured in our studies, the fact that aprotinin 6 and amiloride 8 both inhibit glandular kallikrein activity strongly suggests that their strikingly similar ability to suppress the stimulated rise in PRA produced by furosemide might be mediated via an inhibition of this system.…”
mentioning
confidence: 76%
“…The inhibition of this rise in PRA by amiloride without any significant attenuation of the natriuretic effect of furosemide in the present experiment further strengthens our previous suggestion that the suppression by aprotinin of the furosemide-induced rise in PRA was probably not due to a concomitant suppression of furosemide-induced natriuresis but to an inhibition of renal kallikrein activity. Urinary kallikrein excretion, the commonly used but presumptive index of renal kallikrein activity, is known to be stimulated by furosemide, 10 …”
Section: Discussionmentioning
confidence: 99%